Company Snapshot
- Ticker
- IQV
- Name
- IQV
- Sector
- None
- Currency
- 0
- Relative Volume
- None
- Market Cap
- 37828652000.000000
- Volume
- 1,007,215
- Avg Volume (3M)
- 1,418,237
IQV
IQV
Last update recent
222.26
-3.72
(-1.65%)
Market Cap
37828652000.000000
Dividend Yield
0.00%
1Y Return
None%
Beta
None
Price & Moving Averages
Interactive chart with SMA overlays and intraday breadth.
Profitability
- Revenue
- 15904000000.000000
- EPS
- 7.35
- Dividend / Share
- None
- Total Dividends
- $0.00
- Dividend Yield
- 0.0%
- Net Income
- 1283000000.000000
- Net Margin
- 8.07%
- Payout Ratio
- 0.0%
- Qtly Growth YoY
- None
Valuation & Quality
- P/E
- 29.48
- Forward P/E
- None
- P/S
- 2.38
- P/B
- 6.02
- Beta
- None
- Debt / Equity
- 2.42
- Current Ratio
- 0.70
- Return on Equity
- 0.20%
- Return on Assets
- 0.04%
Technicals & Returns
- Distance vs 200 DMA
- 22.59%
- 200 DMA
- 181.30
- Distance vs 50 DMA
- 2.67%
- 50 DMA
- 216.48
- Return 1Y
- None%
- Return YTD
- None%
- Beta (Trailing)
- None
- Relative Volume
- None
Factor Lens
Plot valuation, momentum, or volume trends.
Seasonal Performance
Company Overview
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision m Read more
- Name
- IQV
- Industry
- Medical - Diagnostics & Research
- CEO
- Mr. Ari Bousbib
- Employees
- 88,000
- IPO Date
- 2013-05-09
- Phone
- 919 998 2000
- Address
- None
- Website
- https://www.iqvia.com
Dividend Yield
0.00%
TTM Distributions
$0.00
Latest News
Curated headlines from premium sources.
CIBC Asset Management Inc Acquires 44,732 Shares of IQVIA Holdings Inc. $IQV
CIBC Asset Management Inc lifted its stake in IQVIA Holdings Inc. (NYSE: IQV) by 18.8% in the second quarter, according to the company in its most recent filin…
IQVIA: Increasingly Indispensable In Drug Development
IQVIA Holdings is positioned as the indispensable data and technology backbone of the life sciences industry, far beyond a traditional CRO. Long-term revenue v…
IQVIA Holdings Inc. $IQV Shares Purchased by Federated Hermes Inc.
Federated Hermes Inc. boosted its holdings in shares of IQVIA Holdings Inc. (NYSE: IQV) by 4.0% during the undefined quarter, according to its most recent 13F …
Fisher Asset Management LLC Sells 10,975 Shares of IQVIA Holdings Inc. $IQV
Fisher Asset Management LLC cut its stake in shares of IQVIA Holdings Inc. (NYSE: IQV) by 55.1% in the undefined quarter, according to the company in its most …
Boston Family Office LLC Sells 10,147 Shares of IQVIA Holdings Inc. $IQV
Boston Family Office LLC lowered its position in IQVIA Holdings Inc. (NYSE: IQV) by 7.6% during the undefined quarter, according to the company in its most rec…
Critical Comparison: IQVIA (NYSE:IQV) versus Tenon Medical (NASDAQ:TNON)
IQVIA (NYSE: IQV - Get Free Report) and Tenon Medical (NASDAQ: TNON - Get Free Report) are both medical companies, but which is the better stock? We will compa…